18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR-TRC-14004233
结束
/
/
/
2014-02-04
/
/
Glaucoma
晶體切除手術或內鏡光凝激光聯合晶體切除手術用於治理慢性原發性閉角型青光眼之研究
晶體切除手術或內鏡光凝激光聯合晶體切除手術用於治理慢性原發性閉角型青光眼之研究
晶體切除手術或內鏡光凝激光聯合晶體切除手術用於治理慢性原發性閉角型青光眼
随机平行对照
其它
randomized
/
Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong
/
25
/
2014-02-13
1990-01-01
/
1. A diagnosis of PACG; 2. Requiring 2 or more IOP-lowering drugs to control IOP, or IOP >21mmHg on maximally tolerable drugs; 3. Able and willing to give informed consent, prior to randomization; 4. Older than 18 years of age.;
登录查看1. Previous intraocular surgery or cyclophotocoagulation, with the exception of laser peripheral iridotomy and argon laser peripheral iridoplasty; 2. Secondary causes of angle closure including iridocorneal-endothelial syndrome, neovascular glaucoma etc.; 3. Unable to cooperate for reliable visual field and OCT examination.;
登录查看Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong
/
药渡2025-01-19
亚泰制药2025-01-19
亚泰制药2025-01-19
约印创投2025-01-16
求实药社2025-01-16
Genhouse2025-01-16
IPHASE2025-01-16
动脉网2025-01-16
动脉网-最新2025-01-16
药明康德2025-01-16